Deerfield Management Company, L.P. (Series C) Dynavax Technologies Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 21,560 shares of DVAX stock, worth $263,247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,560Holding current value
$263,247% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
273Shares Held
130MCall Options Held
451KPut Options Held
203K-
Black Rock Inc. New York, NY21.9MShares$267 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$153 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$113 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$102 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$93.9 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.54B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...